SPARTA Biodiscovery
Ben Peacock is currently the Commercial Director at SPARTA Biodiscovery, a position held since November 2024. Prior to this role, Ben served in various capacities at NanoFCM from March 2019 to November 2024, including Head of Research and Scientific Application and Support Manager, where responsibilities included guiding users in developing protocols and projects for Nano flow cytometry. Between November 2014 and October 2018, Ben was a PhD student at the University of Sheffield, focusing on the characterization of extracellular vesicles from oropharyngeal carcinoma cells, which involved optimizing protocols and teaching methodologies. Ben holds a Master of Science in Molecular Medicine from The University of Sheffield and a Bachelor of Science in Biology from the University of Warwick.
This person is not in any teams
SPARTA Biodiscovery
SPARTA Biodiscovery is a brand-new spin-out company from Imperial College London developing and commercialising the SPARTA® technology. SPARTA® (Single Particle Automated Raman Trapping Analysis) is a breakthrough analytical technology for automated, label-free comprehensive characterisation of nanoformulations. SPARTA® is available through our service offering and in the near future as a benchtop instrument.